Sunday, July 24, 2022

Labcorp blood test identifies signs of neurodegenerative disease

 You just might want this test post stroke so if found you can implement YOUR DOCTOR'S EXACT DEMENTIA PREVENTION PROTOCOLS. Oh, doesn't have any, well then you are screwed, your doctor however keeps on doing their incompetent job inflicting others just as badly. 

Your risk of dementia, has your doctor told you of this?

1. A documented 33% dementia chance post-stroke from an Australian study?   May 2012.

2. Then this study came out and seems to have a range from 17-66%. December 2013.`    

3. A 20% chance in this research.   July 2013.

4. Dementia Risk Doubled in Patients Following Stroke September 2018 

What is your doctor's EXACT PROTOCOL TO PREVENT DEMENTIA?

The latest here:

Labcorp blood test identifies signs of neurodegenerative disease

Labcorp Diagnostics announced the launch of the first widely accessible blood test that provides direct evidence of neurodegeneration and neuronal injury.

In a company press release, the global life sciences firm stated the neurofilament light chain (NfL) test is expected to allow for the identification and verification of signs of neurodegenerative disease and, in turn, will grant physicians a more effective and efficient path to diagnosis and treatment for patients.

Photo of blood test tubes
Source: Adobe Stock.

Elevated NfL levels signal neuronal injury, whether from diseases like multiple sclerosis, Alzheimer’s and Parkinson’s or brain injury, such as with concussion.

One of three main neurofilament types, NfL has been the most commonly studied in research settings, but a reliable NfL test had not been widely available for patient care, according to the release.

NfL is performed on a standard blood collection that can be done at a hospital, physician’s office or at any of Labcorp’s nearly 2,000 patient service centers, the company said.

“NfL is a simple, objective blood test that provides direct evidence of neuronal damage,” Brian Caveney, MD, chief medical officer and president, Labcorp Diagnostics, stated in the release. “In making this test widely available, Labcorp is supporting neurologists with a tool they’ve been asking for that enables faster diagnoses, better treatment decisions and improved patient care.”

No comments:

Post a Comment